BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma. - Wikidata - awgldk - TriplyDB

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q36675461

about

Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.Clinical evaluation of therapeutic cancer vaccines.Vaccination with immunoglobulin frame region-derived nonapeptide elicits cellular immune response against lymphoma in human leukocyte antigen-A2.1 transgenic mice.Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.The promise of the anti-idiotype concept.Immunological monitoring of anticancer vaccines in clinical trials.Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development

P2860

Q35058011-B00C3C59-6658-436F-AF6C-42F3C49F7071 Q35114545-A1FFCB3D-2948-4C5F-84E8-25CB5A50C103 Q36639475-80E9A662-13DA-4316-8F93-C6990B532DA5 Q37142202-96B85227-1E94-4770-8601-F975E3AFC77F Q37354177-070E7E9C-9145-43D3-A2DC-05CD90EF87AF Q37505369-241B3E2A-7F50-40F2-9F3B-C7CA537A5415 Q39527856-565551ED-E420-4FE9-8461-14D2BDEEF014 Q39829133-CBC74B00-F7BF-4F4B-A928-2DDE82F3F8AC Q42419120-7CB18BC0-BE47-4555-A6A3-4F47AB4E6071 Q42734281-5AA1E00D-E716-4FD4-ADFA-ABDD6E435E0C Q57094593-FCD43459-5471-4BF1-BB8D-CD3E631D7922

P2860

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q36675461

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

@ast

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

@en

type

label

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

@ast

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

@en

prefLabel

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

@ast

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

@en

P1433

Q36675461-DA3DD4E1-6A2F-4E80-8D02-7C416FF62F6B

P1476

Q36675461-69554911-4FEB-492F-A20E-456161AA87E6

P2093

Q36675461-4F1D81A4-0217-4FB7-8263-A9D6D01401D6

Q36675461-7DCA4794-C41B-4736-A9A8-3F6A121C7C1D

Q36675461-C09DBF86-9636-4BC2-84EF-9AC4EA33A14B

Q36675461-DBC9779C-15B1-43E3-9BC4-BA093CFD73F6

Q36675461-F995A369-4000-4FE6-8720-1FA9E5D2E38B

P2860

Q36675461-05F0BE99-AC75-48EE-8FA2-A6B7FE0A82F3

Q36675461-07661F1C-426D-4075-9DA8-A8FF276AFCF6

Q36675461-0F29AA9C-8C31-4BE5-8002-BD748F5C8718

Q36675461-1FCC9B73-5AFC-46FE-B28D-547E101E8558

Q36675461-2E63699D-FD98-42F3-8C8B-462EDC6A7FA4

Q36675461-3818AA7A-0DAE-4F56-9A90-E40AFFDB4DCC

Q36675461-38D18A72-3C42-4A1E-A0C1-82FBD6C3C51F

Q36675461-3F4A6303-9E50-48F6-806C-E4ED6CA2B637

Q36675461-461E90D1-E954-4FEC-9203-501AF1D8594A

Q36675461-47D018B6-400F-4294-820F-632A3F60B41E

P304

Q36675461-A386FF5C-0294-46B6-96FC-B25AF8A341B0

P31

Q36675461-81AE539A-1018-4C15-AB54-81AEB971A98F

P356

Q36675461-BA5720C7-237D-41A3-A3BE-61826DCCA0B4

P407

Q36675461-5D22DFBA-193A-44DE-8BBC-99F3F8FEDE5A

P433

Q36675461-E8C1376E-A311-4419-95B7-E2B488B0D14A

P478

Q36675461-90A55A11-3382-4C82-8938-02F8622FD707

P577

Q36675461-95BBC688-BBB9-4917-A576-01719AEACAE7

P698

Q36675461-8564C488-1807-4841-A835-C55D25F32D38

P356

14712598.7.1.113

P1433

Expert Opinion on Biological Therapy

P1476

BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.

@en

P2093

Alison F Woo

http://www.w3.org/2001/XMLSchema#string

Keon-Uk Park

http://www.w3.org/2001/XMLSchema#string

Sattva S Neelapu

http://www.w3.org/2001/XMLSchema#string

Seung-Tae Lee

http://www.w3.org/2001/XMLSchema#string

Yun-Fang Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

Cancer statistics, 2006

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

P304

113-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.7.1.113

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17150023

http://www.w3.org/2001/XMLSchema#string